Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults

Journal of Infectious Diseases
Volume 223, Issue 4, 15 February 2021
https://academic.oup.com/jid/issue/223/4

 

Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults
Jerald Sadoff, Els De Paepe, Wouter Haazen, Edmund Omoruyi, Arangassery R Bastian
The Journal of Infectious Diseases, Volume 223, Issue 4, 15 February 2021, Pages 699–708, https://doi.org/10.1093/infdis/jiaa409
Coadministration of Fluarix with the Ad26.RSV.preF vaccine had an acceptable safety profile and showed no evidence of interference in immune response in healthy adults aged ≥60 years.